We are live on ! Find out more
SMTI icon

Sanara MedTech
SMTI

52 hedge funds and large institutions have $31.4M invested in Sanara MedTech in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 19 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

11% more capital invested

Capital invested by funds: $28.3M → $31.4M (+$3.13M)

6% more funds holding

Funds holding: 49 → 52 (+3)

2.15% more ownership

Funds ownership: 10.3% → 12.45% (+2.2%)

11% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 19

Holders
52
Holders Change
+3
Holders Change %
+6.12%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
8
Increased
17
Reduced
19
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
+$1.27M
2
BlackRock
BlackRock
New York
+$972K
3
HSBC Holdings
HSBC Holdings
United Kingdom
+$402K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$277K
5
Millennium Management
Millennium Management
New York
+$248K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$614K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$330K
3
N
Nuveen
North Carolina
-$326K
4
Squarepoint
Squarepoint
New York
-$257K
5
Goldman Sachs
Goldman Sachs
New York
-$203K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$6.91M +$972K +32,429 +15%
Vanguard Group
2
Vanguard Group
Pennsylvania
$5M -$614K -20,483 -10%
SWM
3
Stonebridge Wealth Management
Illinois
$3.4M +$3.59M +119,663 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$2.21M -$330K -11,014 -12%
Marshall Wace
5
Marshall Wace
United Kingdom
$2.03M +$1.27M +42,237 +144%
State Street
6
State Street
Massachusetts
$1.85M +$61K +2,036 +3%
Renaissance Technologies
7
Renaissance Technologies
New York
$1.06M +$93K +3,100 +9%
Northern Trust
8
Northern Trust
Illinois
$970K -$198K -6,594 -16%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$936K +$149K +4,966 +18%
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$927K +$29.9K +996 +3%
Janney Montgomery Scott
11
Janney Montgomery Scott
Pennsylvania
$711K -$38.5K -1,285 -5%
Citadel Advisors
12
Citadel Advisors
Florida
$647K +$220K +7,350 +48%
Morgan Stanley
13
Morgan Stanley
New York
$599K +$151K +5,049 +31%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$389K -$5.76K -192 -1%
HSBC Holdings
15
HSBC Holdings
United Kingdom
$382K +$402K +13,393 New
SI
16
Stephens Inc
Arkansas
$363K +$58.5K +1,952 +18%
SIC
17
Salem Investment Counselors
North Carolina
$318K – – –
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$263K +$277K +9,250 New
Charles Schwab
19
Charles Schwab
California
$262K -$64K -2,135 -19%
Barclays
20
Barclays
United Kingdom
$251K +$133K +4,442 +101%
JP Morgan Chase
21
JP Morgan Chase
New York
$248K -$89.3K -2,978 -25%
Millennium Management
22
Millennium Management
New York
$235K +$248K +8,266 New
HF
23
HRT Financial
New York
$228K +$241K +8,053 New
UBS Group
24
UBS Group
Switzerland
$221K +$71.2K +2,375 +44%
Squarepoint
25
Squarepoint
New York
$201K -$257K -8,560 -55%
1
2 3

SMTI Hedge Fund Activity: Q2 2025 in Review

52 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q2 2025, worth a combined $31.4M — up 11% from $28.3M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new SMTI positions and 5 closed out — a net gain of 3 holders — while 17 added to existing stakes and 19 trimmed.

The largest buyer was Marshall Wace, adding an estimated $1.27M. The largest seller was Vanguard Group, cutting an estimated $614K.

  • 52 institutional investors held Sanara MedTech (SMTI) as of Q2 2025, up from 49 in Q1 2025.
  • Funds reported $31.4M of Sanara MedTech stock for Q2 2025, up 11% quarter-over-quarter.
  • 8 funds opened new Sanara MedTech positions in Q2 2025 and 5 closed out, a net change of +3 holders.
  • The largest Sanara MedTech buyer in Q2 2025 was Marshall Wace, an estimated $1.27M added.
  • The largest Sanara MedTech seller in Q2 2025 was Vanguard Group, an estimated $614K sold.

Based on aggregated 13F filings for Q2 2025.